Stock Details
ALC is Alcon Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 61.04$. Average daily volumn in 3 months 1.03M. Market cap 34.49B



Stock symbol : ALC. Exchange : NYSE. Currency : USD
Lastest price : 70.07$. Total volume : 909.38k. Market state PRE
Click reload if you want to check the lastest price on market!!!

Alcon Inc. (ALC)
Last Price
70.07$
Change
1.18
Volume
909.38k

Previous Close68.89
Open69.31
Day Range69.23-70.24
Bid70.16 x 1k
Ask70.24 x 1.1k
Volume909.38k
Average Volume1.03M
Market Cap34.49B
Beta0.74
52 Week Range55.21-88.78
Trailing P/E60.93
Foward P/E27.92
Dividend (Yield %)0.30%
Ex-Dividend Date2022-05-03



Financial Details


According to Alcon Inc.'s financial reports the company's revenue in 2021 were 8.29B an increase( +33.33%) over the years 2020 revenue that were of 6.83B. In 2021 the company's total earnings were 376M while total earnings in 2020 were -531M(-170.81%).


Loading ...



Organization

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion ... vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Market Cap:
34.49B
Revenue:
8.29B
Total Assets:
28B
Total Cash:
1.57B



News about "Alcon Inc."

alcon-prices-us13-billion-senior-notes-offering-image

Alcon Prices US$1.3 Billion Senior Notes Offering

Source from : YAHOO!Finance - 2 days ago

The offering is expected to close on December 6, 2022, subject to customary closing conditions. Alcon intends to use the proceeds from the offering for general corporate purposes, including the ...See details»


Alcon's (ALC) Latest Buyout to Enhance Its Product Portfolio

Source from : Yahoo Finance - 7 days ago

Alcon Inc. ALC recently completed its Aerie Pharmaceuticals, Inc. acquisition, announced in August this year. Following the completion, Alcon intends to integrate Aerie into its business.See details»


Alcon (ALC) Q3 Earnings Surpass Estimates, Sales Guidance Cut

Source from : Nasdaq - 9 days ago

Alcon Inc. ALC delivered core earnings per share (EPS) of 50 cents for the third quarter of 2022. Earnings were down 7% from the year-ago quarterโ€™s figure (up 14% at constant exchange rate or CER).See details»


Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Companyโ€™s Ophthalmic Pharmaceutical Business

Source from : Morningstar%2c Inc. - 10 days ago

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has completed its acquisition of Aerie Pharmaceuticals, Inc. (NASDAQ ...See details»


Alcon Inc. (ALC) Q3 2022 Earnings Call Transcript

Source from : Seeking Alpha - 15 days ago

Greetings. And welcome to the Alcon Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.See details»


Durham loses public company HQ with Alcon-Aerie deal complete

Source from : The Business Journals - 9 days ago

Alcon (NYSE: ALC) announced Tuesday it has closed its deal for Aerie Pharmaceuticals, which previously traded on the Nasdaq under the ticker AERI, adding two commercial products to the Geneva ...See details»


Alcon Inc.'s (VTX:ALC) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Source from : Yahoo News - 1 month ago

With its stock down 19% over the past three months, it is easy to disregard Alcon (VTX:ALC). But if you pay close attention, you might find that its key financial indicators look quite decent, which ...See details»


Alcon Inc. 2022 Q3 - Results - Earnings Call Presentation

Source from : Seeking Alpha - 16 days ago

Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site ...See details»


Alcon Reports Third Quarter 2022 Results

Source from : Stockhouse - 16 days ago

The Company ended the third quarter with a net debt(4) position of $2.7 billion. Expected acquisition of Aerie Pharmaceuticals, Inc. On August 22, 2022, Alcon and Aerie Pharmaceuticals, Inc. announced ...See details»


Is it a Good Time to Increase Your Alcon (ALC) Position?

Source from : Yahoo! Sports - 1 month ago

In its Q3 2022 investor letter, Madison Investors Fund mentioned Alcon Inc. (NYSE:ALC) and explained its insights for the company. Founded in 1945, Alcon Inc. (NYSE:ALC) is a Geneva, Switzerland ...See details»


Alcon Inc.

Source from : Wall Street Journal - 2 years ago

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...See details»


Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Companyโ€™s Ophthalmic Pharmaceutical Business

Source from : Yahoo - 10 days ago

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has completed its acquisition of Aerie Pharmaceuticals, Inc. (NASDAQ ...See details»


Alcon Reports Third Quarter 2022 Results

Source from : Benzinga.com - 16 days ago

Expected acquisition of Aerie Pharmaceuticals, Inc. On August 22, 2022, Alcon and Aerie Pharmaceuticals, Inc. announced the companies had entered into a definitive merger agreement through which ...See details»


Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Companyโ€™s Ophthalmic Pharmaceutical Business

Source from : newsroom.businesswire.com - 10 days ago

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has completed its acquisition of Aerie Pharmaceuticals, Inc. (NASDAQ ...See details»